BMC Cancer · 2019 · 18 citations · 15 references
MedicineOncologyPharmacologyCancer PharmacologyMetastasisOncology PharmacotherapyBlood-brain Barrier PenetrationBrain MetastasesMetastatic Breast CancerMetastatic Disease TreatmentSystemic Therapy For Breast CancerToxicity ManagementBlood-brain Barrier PermeabilityBrain Metastasis Systemic TherapyDurable Clinical ResponseHigh-dose Methotrexate PharmacokineticsHigh-dose Methotrexate TherapyIntrathecal MethotrexateMetastatic Breast Cancer TreatmentPartial Response Assessment
BACKGROUND: Infusion of high-dose intravenous methotrexate (MTX) has been demonstrating to penetrate the blood-brain barrier. The aim of this present study was to assess the efficacy and safety of high dose MTX in patients with central nervous system (CNS) metastases of breast cancer. METHODS: Twenty-two patients with CNS metastases treated by MTX (3 g/m2) between April 2004 and October 2009 were enrolled. Clinical response rate, time to progression (TTP), overall survival (OS), and safety were assessed. RESULTS: In terms of brain metastases, 2 patients (9%) achieved a partial response, 10 patients (45%) had disease stabilization, and 10 patients (45%) had disease progression. In others metastatic sites, 7 patients (39%) achieved a disease stabilization, and 11 patients (61%) had disease progression. TTP and OS were 2.1 (95%CI 1.4-2.9) and 6.3 (95%CI 1.8-10) months, respectively. CONCLUSION: . Nonetheless, the favorable toxicity profile should suggest the possibility to increase the dosage and further study are planned.
15
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Kim Margolin, Marc S. Ernstoff, Omid Hamid et al. · The Lancet Oncology · 2012 · 1.1K citations
Medicine, Oncology, Pharmacology +12
Central nervous system metastasis from breast carcinoma autopsy study
Yoshiaki Tsukada, Ahmed Fouad, John W. Pickren et al. · Cancer · 1983 · 1.1K citations
Sarah B. Goldberg, Scott Gettinger, Amit Mahajan et al. · The Lancet Oncology · 2016 · 996 citations · Full text
Medicine, Oncology, Pharmacology +16